MMU Research and Knowledge Exchange Blog

Funding opportunities, news and guidance from RKE at Manchester Metropolitan University


Leave a comment

Alzheimer’s Research UK Grant Schemes

Alzheimer’s Research UK has a large number of different grant schemes through which you can apply for funding. All applications must fall within Charities’s remit which covers biomedical research in Alzheimer’s disease and other dementias.

Grant schemes: Network Support Grants, Equipment Grants and Sabbatical Grants.

Deadline: 20 April

Grant schemes: Global Clinical Trials Fund.

Deadline: 11 May

Grant schemes: Project Grants, Interdisciplinary Research Grants, Senior Research Fellowships, Research Fellowships, Travelling Research Fellowships and Clinical Research Fellowships, Network Support Grants.

Deadline: 6 July

For more information, please visit the Alzheimer’s Research UK Grants page.

For support during your application, please contact Research Development.


Leave a comment

Study shows beneficial effects of blocking brain inflammation in an experimental model of Alzheimer’s

Take a look at this article detailing new research on Alzheimer’s disease funded by the MRC and Alzheimer’s Research UK.

A study, published today in the journal Brain, has found that blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behaviour changes seen in the progression of Alzheimer’s disease. The research was jointly funded by the MRC and Alzheimer’s Research UK.

It was originally thought that Alzheimer’s disease disturbs the brain’s immune response, but this latest study adds to evidence that inflammation in the brain can in fact drive the development of the disease. The findings suggest that by reducing this inflammation, progression of the disease could be halted.

The team hope the discovery will lead to an effective new treatment for the disease, for which there is currently no cure.

To read more, please visit: http://bit.ly/1Odncn9


Leave a comment

Alzheimer’s Society Funding

The Alzheimer’s Society invites applications for several funding opportunities.

Project grants

These support research into the cause, cure, care or prevention of any form of dementia.

Junior fellowships

These support postdoctoral researchers who have shown exceptional promise at the start of their research career.

Senior fellowships

These support postdoctoral researchers or other successful researchers who wish to build on a number of successful years of dementia research, and who demonstrate ambition and potential to be independent investigators.

The deadline for applications is 18 Mar 16.

For more information, visit: http://bit.ly/1OuulAQ

For support during your application, please contact your relevant Research Development Manager.


Leave a comment

Alzheimer’s Society: Autumn Grant Round Details

Alz Society Logo Applications are open for the Alzheimer’s Society’s project grants, fellowships and PhD Studentship grants. The deadline for applications is Midday 18th September 2015.

Quick overview of the schemes and the funding available.

Project Grants: Fund up to £400K of direct costs over a 36 month period.  Project grants are for researcher led applications to enable world-class research in to the cause, cure, care or prevention of any form of dementia.

Further information can be assessed here

Fellowship Grants: Funds up to £225K (including the fellow’s salary) over a 36 month period. Junior Fellowships are for post-doctoral researchers who have shown exceptional promise at the start of their research career. Applicants should demonstrate potential to be an independent researcher.

Fellowships are open to researchers from all disciplines, health and care professions, in line with Alzheimer’s Society’s vision to increase capacity.

Further information can be assessed here

PhD Studentships: Funding of up to £85,000 is provided for up to three years and includes a stipend (£15,000-£16,000 per year), university PhD fees at EU rates, consumables & equipment, and conference dissemination support. Please note: Students must have at least a 2.1 degree.

Further information can be assessed here

 


Leave a comment

NEW FUNDING ALERT: Alzheimer’s Society, Implementation grants

Alzeimer's Society LogoThe Alzheimer’s Society is launching a new grant scheme in 2015 to enable the scaling-up of promising non-drug treatments, programmes and services to improve the health and well-being of people affected by dementia.

The implementation grant scheme is open to people looking to move dementia care, services and public health research into practice.

Further Details: Applicants can apply for grants of up to £400,000 that will either:

a) enable the scale-up of evidence based interventions that have been shown to improve care and are ready to be implemented at a larger scale, or;
b) lay the foundations for the scale-up of evidence based interventions; preparatory work and testing the feasibility of bringing dementia research knowledge into the real world.

All applications must:

  • demonstrate involvement of appropriate end users of the research in the development and delivery of the proposal
  • proposals must demonstrate sufficient evidence, for example from up to date systematic reviews, that the intervention is ready to be moved into the outside world.
  • use methods for enabling change that are grounded in theory.

Outline Application Deadline: 21st August 2015

Further details: http://www.alzheimers.org.uk/implementation

Please contact the RKE office to discuss your ideas!


Leave a comment

New global funding call: Alzheimer’s Association, The Michael J. Fox Foundation and the Weston Brain Institute

news   New global funding call, joint with the Alzheimer’s Association, The Michael J. Fox Foundation and the Weston Brain Institute.
Biomarkers Across Neurodegenerative Diseases (BAND2) aims to stimulate analyses of existing datasets across Alzheimer’s, Parkinson’s and other neurodegenerative diseases to increase understanding of similarities and differences in their pathogenesis. This scheme is open to researchers in both the UK and beyond, and post-doctoral researchers are eligible to apply as a principal investigator. Applicants may request up to two years and $150,000 in costs.

The study of existing well-annotated and defined cohorts is a requirement. Grant proposals could address, but are not limited to, the following areas of study:

  1. Analysis of existing neurodegenerative disease datasets.
  2. Standardisation of data acquisition/methods/quality control/assays.
  3. Biomarker cross-talk between neurodegenerative diseases.
  4. Investigate common mechanisms across the broader spectrum of neurodegenerative diseases.
  5. Investigate age-related changes and risk factors for neurodegeneration.

Letters on intent are due on 9 April, with full applications (by invitation) due on 26 June. Please visit the Alzheimer’s Association website for more information.


Leave a comment

Early Warning : Jan 2015 Call on Neurodegenerative Disease

JPND

The EU Joint Programme on Neurodegenerative Disease Research (JPND) have preannounced their first call for proposals, which will launch in January 2015. We’ll update you as soon as the call information is released, but the following information from the JPND website gives a preview of what to expect. As ever, if you think this opportunity could be of interest please do get in touch (euro_res@mmu.ac.uk).

(Taken from JPND website)

The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly begin a major new cohesive action with the European Commission – the first concrete synergy between JPND and Horizon 2020 designed to address the global threat of neurodegenerative diseases.

As part of this new initiative, JPND will launch a joint transnational call for proposals in January 2015 aimed at supporting transnational research collaborations in three JPND priority areas:

  • Longitudinal Cohorts
  • Advanced Experimental Models
  • Risk and Protective Factors

The aim of the call is to support a limited number of ambitious, high level, innovative, multi-national and multi-disciplinary collaborative research projects that will add value to the respective research areas.

The call will see more than 30 million euro being made available by JPND member countries, including a significant additional European Commission “topping up” component of up to 30%.

This will be a 2-step call, anticipated to launch in early January 2015, with a likely first stage (pre-proposal submission) deadline of March 2015.

Further detail will be provided at the time of the call launch date in January 2015. However, the indicative titles of each call topic are provided below:

Topic 1: Genetic, epigenetic and environmental risk and protective factors of neurodegenerative diseases:

Due to the phenomenal number of high quality proposals received but unsupported under the 2012 JPND joint transnational call, JPND is re-launching a call topic in this area. Examples of areas covered under this topic again include identification of novel genetic, epigenetic and environmental risk and protective factors associated with neurodegenerative disorders in animal, cell and human studies.

Topic 2: Longitudinal cohorts in neurodegenerative disease research:

The key priority under this topic will be to enhance the capabilities of existing longitudinal cohort studies, or linking related studies to address key questions through a synergistic approach. This topic will aim to build upon the report of the JPND Action Group in this area as well as referencing the ongoing work of the JPND Working Groups, supported under the 2014 JPND “rapid action” call.

Topic 3: Advanced experimental models of neurodegenerative diseases:

This topic will focus on the encouragement of a next generation of reliable and well characterized animal and cell models for neurodegenerative diseases, building upon the report of the JPND Action Group in this area. This may include the development of novel animal models for specific diseases to better reproduce the complexity of the clinical features of the disease in humans, the enhancement of existing animal models (e.g. by fostering a deeper characterization of the phenotypes and pathologies), and the exploitation of novel (or the improvement of existing) neuronal, neuronal-like cells or inducible pluripotent stem (iPS) cells, generated from different sources.

Please Note:

  • Proposals are not limited to each topic, and may cover two or more topics.
  • JPND countries may support one, two or three call topics so applicants will need to take this into consideration.
  • Call applicants are encouraged to take advantage of the JPND online partnering tool to showcase their research group’s expertise, search for appropriate partners and pitch call-related ideas. An improved, multi-lingual version of the pilot tool is now available here.
  • All information regarding future JPND Call topics is indicative and subject to change.
  • Final call information will be published on the JPND website.

The JPND diseases are:
Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD‐related disorders, Prion disease, Motor neurone diseases (MND), Huntington’s disease (HD), Spinocerebellar ataxia (SCA), Spinal muscular atrophy (SMA)